KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Depreciation & Amortization (CF) (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Depreciation & Amortization (CF) for 6 consecutive years, with -$501000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 114.43% year-over-year to -$501000.0, compared with a TTM value of -$1.8 million through Dec 2025, down 238.47%, and an annual FY2025 reading of -$1.8 million, down 238.47% over the prior year.
  • Depreciation & Amortization (CF) was -$501000.0 for Q4 2025 at Clover Health Investments, up from -$2.2 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $3.7 million in Q3 2023 and bottomed at -$3.5 million in Q4 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $5421.1, with a median of $318000.0 recorded in 2024.
  • Peak annual rise in Depreciation & Amortization (CF) hit 1488.46% in 2022, while the deepest fall reached 1683.33% in 2022.
  • Year by year, Depreciation & Amortization (CF) stood at -$198000.0 in 2021, then tumbled by 1683.33% to -$3.5 million in 2022, then skyrocketed by 204.45% to $3.7 million in 2023, then decreased by 5.88% to $3.5 million in 2024, then plummeted by 114.43% to -$501000.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for CLOV at -$501000.0 in Q4 2025, -$2.2 million in Q3 2025, and $394000.0 in Q2 2025.